Protein phosphatase 2A plays a central role in controlling many cell signaling pathways, which are frequently disrupted ...

NYU Langone Health today announced the appointment of Vivek Subbiah, MD, as director of the Early-Phase Drug Development ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Could a selfie predict your chances of cancer survival? Researchers are developing artificial intelligence tools to do just ...

Add Yahoo as a preferred source to see more of our stories on Google. Haylie Helms, M.S., an OHSU graduate student in biomedical engineering, is lead author on a review in Nature Reviews. Helms works ...

Thousands of single changes in the nucleotides that make up the human genome have been associated with an increased risk of developing cancer. But until now, it’s not been clear which are directly ...

Why do some lung cancers stop responding to drugs that once worked? And why does the immune system sometimes fail to recognize and destroy tumors? Pathologist Katerina Politi, PhD, has spent more than ...

We also hoped to identify new targets that could lead to new drug developments," said Zhang, a McNair scholar and member of Baylor's Dan L Duncan Comprehensive Cancer Center. The team applied the data ...

The growth and death of cancer cells in the lab are studied primarily in two-dimensional cell cultures. In a study published ...

The gut microbiome plays a crucial role in cancer development and progression, by influencing the host immune system and metabolism. Dysbiosis, or a disruption in the balance of the host gut ...